New pill targets advanced cancers in first human test
NCT ID NCT07480681
Summary
This is the first study in people to test a new oral drug called HLX97. It aims to find a safe dose and see early signs of whether it can help control advanced cancers that have spread. The trial will enroll about 138 adults with specific advanced solid tumors, like certain breast, prostate, and lung cancers, who have run out of standard treatment options.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ADVANCED/METASTATIC SOLID TUMORS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.